No Picture
PR Newswire

General Automation Lab Technologies (GALT) Partners with Lawrence Livermore National Laboratory (LLNL) to Improve Biofuel Production

New $1.5 million DOE grant will utilize GALT’s novel high throughput microbiome research platform to improve algal biofuel growth through microbiome engineering

SAN FRANCISCO, Dec. 14, 2017 /PRNewswire/ — Lawrence Livermore National Laboratory has … […]

No Picture
PR Newswire

GigaGen CEO David Johnson to Present at 2017 Antibody Engineering & Therapeutics Meeting

SOUTH SAN FRANCISCO, Calif., Dec. 14, 2017 /PRNewswire/ — GigaGen Inc., a biopharmaceutical company developing novel antibody therapies, today announced that David Johnson, Ph.D., chief executive officer, will present at the 2017 Antibody Engineeri… […]

No Picture
PR Newswire

OncoSec Announces Dosing of First Patient in Registration-Directed Phase 2b Clinical Trial, PISCES/KEYNOTE-695, of ImmunoPulse® IL-12 in Combination with Pembrolizumab

SAN DIEGO, Dec. 14, 2017 /PRNewswire/ — OncoSec Medical Incorporated (“OncoSec” or the “Company”) (NASDAQ:ONCS), a company developing intratumoral cancer immunotherapies, today announced the initiation of patient dosing in PISCES/KEYNOTE-695, the c… […]

No Picture
PR Newswire

Trovagene Submits Protocol to FDA for Phase 2 Clinical Trial of PCM-075 in Combination with Zytiga® for Metastatic Castration-Resistant Prostate Cancer

PCM-075, Trovagene’s Polo-like Kinase 1 (PLK1) inhibitor enhances activity of abiraterone in mCRPC tumor cells and may represent a novel combination treatment option in mCRPC

SAN DIEGO, Dec. 14, 2017 /PRNewswire/ — Trovagene, Inc. (NASDAQ: TROV), a … […]